Exane Derivatives’s Constellation Brands STZ Stock Holding History

Exane Derivatives’s Portfolio STZ Stock Details STZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$37.3K	Sell	160 -3	-2%	-$730	0.02%	332
2022 Q1	$37.5K	Hold	163	–	–	0.01%	601
2021 Q4	$40.9K	Buy	163 +160	+5,333%	+$36.5K	0.01%	518
2021 Q3	$632	Hold	3	–	–	﹤0.01%	915
2021 Q2	$676	Hold	3	–	–	﹤0.01%	914
2021 Q1	$684	Hold	3	–	–	﹤0.01%	765
2020 Q4	$657	Sell	3 -6	-67%	-$1.18K	﹤0.01%	713
2020 Q3	$1.71K	Hold	9	–	–	﹤0.01%	576
2020 Q2	$1.57K	Sell	9 -8	-47%	-$1.33K	﹤0.01%	520
2020 Q1	$2.44K	Hold	17	–	–	﹤0.01%	485
2019 Q4	$3.24K	Sell	17 -231	-93%	-$43.6K	﹤0.01%	462
2019 Q3	$51.4K	Sell	248 -12,798	-98%	-$2.57M	0.01%	367
2019 Q2	$2.57M	Buy	13,046 +5,170	+66%	+$1.01M	0.45%	66
2019 Q1	$1.38M	Buy	7,876 +5,402	+218%	+$910K	0.27%	88
2018 Q4	$398K	Buy	2,474 +200	+9%	+$39.7K	0.07%	198
2018 Q3	$493K	Buy	2,274 +1,155	+103%	+$246K	0.09%	164
2018 Q2	$245K	Buy	1,119 +969	+646%	+$219K	0.04%	244
2018 Q1	$32.8K	Sell	150 -7,096	-98%	-$1.56M	0.01%	373
2017 Q4	$1.66M	Sell	7,246 -1,643	-18%	-$355K	0.29%	59
2017 Q3	$1.77M	Buy	8,889 +8,303	+1,417%	+$1.64M	0.33%	57
2017 Q2	$114K	Sell	586 -1,059	-64%	-$188K	0.02%	261
2017 Q1	$267K	Sell	1,645 -26,502	-94%	-$4.13M	0.06%	176
2016 Q4	$4.31M	Buy	28,147 +27,285	+3,165%	+$4.33M	0.85%	19
2016 Q3	$144K	Sell	862 -80,304	-99%	-$13.2M	0.02%	218
2016 Q2	$13.4M	Buy	81,166 +81,165	+8,116,500%	+$12.7M	2.22%	5
2016 Q1	$151	Hold	1	–	–	﹤0.01%	514
2015 Q4	$142	Hold	1	–	–	﹤0.01%	445
2015 Q3	$125	Hold	1	–	–	﹤0.01%	484
2015 Q2	$116	Hold	1	–	–	﹤0.01%	490
2015 Q1	$116	Sell	1 -1	-50%	-$113	﹤0.01%	487
2014 Q4	$196	Buy	+2	New	+$183	﹤0.01%	497

Other funds holding STZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.7B AUM 13.92% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exane Derivatives's STZ Position: Q2 2022 in Review

Exane Derivatives reduced its Constellation Brands (STZ) stake by 1.8% in Q2 2022, selling an estimated $730 and leaving 160 shares worth $37.3K. The position accounts for 0.02% of the portfolio, ranked #332.

Exane Derivatives first reported a position in STZ in Q4 2014 and has held it in 31 quarters since. The position peaked at $13.4M in Q2 2016. 1,216 funds tracked by Wall St. Rank hold STZ as of Q2 2022.

Exane Derivatives held 160 shares of Constellation Brands worth $37.3K as of Q2 2022.
Exane Derivatives sold 3 Constellation Brands shares in Q2 2022, an estimated $730.
Constellation Brands made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #332 holding.
Exane Derivatives first reported a position in Constellation Brands in Q4 2014 and has held it in 31 quarters since.
Exane Derivatives's Constellation Brands position peaked at $13.4M in Q2 2016.
1,216 funds tracked by Wall St. Rank held Constellation Brands as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.